The aim of this study is test the efficacy of a comprehensive self-management therapy to decrease abdominal pain/discomfort and improve quality of life in patients with irritable bowel syndrome (IBS) compared to IBS patients receiving their usual care.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
92
Comprehensive Self-Management includes 8 sessions that cover education, diet, relaxation training, and cognitive behavioral strategies as they related to symptoms of IBS
University of Washington
Seattle, Washington, United States
Daily abdominal pain
Time frame: Baseline, three and six months post randomization
IBS Quality of Life Questionnaire
Time frame: Baseline, three and six months post randomization
Salivary cortisol
Time frame: Baseline, three and six months post randomization
Interleukin-10(IL-10) and Interleukin-12(IL-12)
Time frame: Baseline, three and six months post randomization
Fecal calprotectin
Time frame: Baseline, three and six months post randomization
Intestinal permeability (urine)
Time frame: Baseline, three and six months post randomization
Brief Symptom Inventory
Time frame: Baseline, three and six months post randomization
Cognitive Scale for Functional Bowel Disorders
Time frame: Baseline three and six months post randomization
Work Productivity & Activity Impairment
Time frame: Baseline, three and six months post rand
Daily symptoms(other GI and psychological)
Time frame: Baseline, three and six months post randomization
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.